The World Health Organization (WHO) has formally acknowledged the notification from the United States regarding its intent to withdraw from the international body, a decision the agency stated it deeply regrets and believes will diminish both American and global health security. This significant development marks a pivotal moment for international public health cooperation, prompting a robust defense from the WHO of its foundational principles, historical achievements, and its handling of the unprecedented COVID-19 pandemic. The impending departure of a founding and historically influential member nation, set to take effect in July 2021, raises profound questions about the future trajectory of multilateral health initiatives and the agency’s operational capacity.
Established in 1948, the WHO emerged from the ashes of World War II as a specialized agency of the United Nations, tasked with coordinating international health efforts. The United States played a crucial role in its inception and has been a cornerstone of its operations for over seven decades. American scientific expertise, financial contributions, and diplomatic leadership have been integral to many of the WHO’s most celebrated successes. Historically, the collaborative efforts between the U.S. and the WHO have led to monumental achievements, including the global eradication of smallpox – a feat widely considered one of humanity’s greatest public health victories. Beyond smallpox, the partnership has driven significant progress against a formidable array of infectious diseases such as polio, HIV/AIDS, Ebola, and influenza, as well as persistent threats like tuberculosis, malaria, and neglected tropical diseases. Furthermore, the two entities have worked in concert on critical emerging issues, including antimicrobial resistance and food safety standards. The WHO emphasizes that these collective accomplishments underscore the profound impact of sustained international engagement in tackling shared health challenges.
The formal notification of withdrawal triggers a specific procedural path within the WHO’s governance structure. The implications of this decision are slated for consideration by the WHO Executive Board during its regular meeting commencing in February, with further deliberation anticipated at the annual World Health Assembly in May 2026. These bodies represent the collective will of the WHO’s 194 Member States and will be instrumental in addressing the legal, financial, and operational ramifications of the U.S. departure. The withdrawal process itself is governed by the terms of the WHO Constitution, which requires a one-year notice period and the fulfillment of all financial obligations prior to departure.
Central to the U.S. administration’s rationale for its withdrawal were pointed criticisms directed at the WHO’s performance, particularly concerning the initial phase of the COVID-19 pandemic. Statements from the U.S. government alleged that the WHO had "trashed and tarnished" its reputation, insulted the United States, and compromised its independence. Furthermore, the U.S. accused the WHO of "failures during the COVID-19 pandemic," specifically citing "obstructing the timely and accurate sharing of critical information" and subsequently "concealing those failures." These accusations painted a picture of an organization allegedly swayed by external pressures and deficient in its primary mission during a global health crisis.
In response to these serious allegations, the WHO has mounted a vigorous defense, asserting its unwavering commitment to impartiality and its constitutional mandate to serve all nations without bias. The organization unequivocally states that, as with every Member State, it has consistently engaged with the United States in good faith, maintaining full respect for its sovereignty. Regarding the criticisms of its COVID-19 response, the WHO firmly stands by its actions throughout what it describes as an "unprecedented global health crisis." The agency contends that while no organization or government navigated the pandemic perfectly, its own response was characterized by speed, transparency, and an evidence-based approach.
The WHO provided a detailed timeline of its initial actions as the novel coronavirus emerged. On December 31, 2019, immediately upon receiving reports of a cluster of "pneumonia of unknown cause" in Wuhan, China, the WHO promptly requested additional information from Chinese authorities and activated its emergency incident management system. By January 11, 2020, when the first death was reported from China, the WHO had already disseminated alerts globally through official channels, public statements, and social media. It had convened international experts and published comprehensive guidance for countries on safeguarding their populations and health systems. A critical juncture came on January 30, 2020, when the WHO Director-General declared COVID-19 a Public Health Emergency of International Concern (PHEIC) under the International Health Regulations – the highest level of alarm under international health law. At that point, outside of mainland China, fewer than 100 cases had been reported worldwide, and there were no recorded deaths, highlighting the WHO’s early warning.
Throughout the initial weeks and months of the pandemic, the Director-General repeatedly urged all countries to take immediate, decisive action to protect their populations. He issued stark warnings, emphasizing that "the window of opportunity is closing," declaring "this is not a drill," and describing COVID-19 as "public enemy number one." The WHO further clarified its advisory role, stating that while it recommended key public health measures such as the use of masks, vaccines, and physical distancing, it never mandated their implementation or imposed lockdowns. The organization maintains that its function is to provide guidance based on the best available scientific evidence, while the ultimate decisions regarding national policy and enforcement rest with sovereign governments, who act in what they believe are the best interests of their citizens.
Addressing the U.S. claim that the WHO "pursued a politicized, bureaucratic agenda driven by nations hostile to American interests," the organization explicitly refutes this assertion. As a specialized agency of the United Nations, governed by its 194 Member States, the WHO underscores its inherent impartiality. Its fundamental purpose, it states, is to serve all countries equitably, upholding their sovereignty and operating "without fear or favour." The WHO’s operational framework and decision-making processes are designed to be consensus-driven, reflecting the diverse perspectives and needs of its global membership rather than being beholden to any single national interest.
In the wake of the pandemic, and in response to numerous global reviews of the COVID-19 response – including assessments of its own performance – the WHO has taken proactive measures to strengthen its internal operations and bolster countries’ pandemic preparedness and response capacities. The agency highlights the continuous operation of its emergency systems, developed before, during, and after the acute phase of the pandemic, which it asserts have contributed to the safety of all nations, including the United States. These efforts include ongoing work to refine global health regulations, enhance surveillance networks, and improve the speed and equity of response mechanisms.
The WHO expressed profound appreciation for the continued support and engagement of its remaining Member States, who persist in collaborating within the organization’s framework to address the world’s most pressing health challenges, spanning both communicable and noncommunicable diseases. A significant recent development in this regard is the adoption of the WHO Pandemic Agreement by Member States last year. Once ratified, this landmark instrument of international law is envisioned to significantly enhance global readiness and response to future pandemics, fostering greater international cooperation and solidarity. Furthermore, Member States are currently engaged in negotiations for an annex to this agreement: the Pathogen Access and Benefit Sharing system. If adopted, this system aims to promote the rapid detection and transparent sharing of pathogens with pandemic potential, coupled with ensuring equitable and timely access to essential vaccines, therapeutics, and diagnostics for all countries.
Despite the impending departure of the United States, the WHO remains steadfast in its core mission and constitutional mandate: to ensure the highest attainable standard of health as a fundamental human right for all people, everywhere. The organization holds out hope for a future wherein the United States will resume active participation in its vital work, recognizing the interconnected nature of global health and the indispensable role of collective action in safeguarding humanity against emerging and persistent health threats. The withdrawal underscores the ongoing tension between national sovereignty and global interdependence in the face of universal health challenges, leaving the global health architecture in a state of profound reassessment.
About the Author
